These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 18930776)

  • 1. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
    Geisbert TW; Daddario-Dicaprio KM; Geisbert JB; Reed DS; Feldmann F; Grolla A; Ströher U; Fritz EA; Hensley LE; Jones SM; Feldmann H
    Vaccine; 2008 Dec; 26(52):6894-900. PubMed ID: 18930776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
    Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
    J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.
    Marzi A; Engelmann F; Feldmann F; Haberthur K; Shupert WL; Brining D; Scott DP; Geisbert TW; Kawaoka Y; Katze MG; Feldmann H; Messaoudi I
    Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1893-8. PubMed ID: 23319647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
    Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
    Mire CE; Geisbert JB; Marzi A; Agans KN; Feldmann H; Geisbert TW
    PLoS Negl Trop Dis; 2013; 7(12):e2600. PubMed ID: 24367715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
    Mire CE; Geisbert JB; Agans KN; Satterfield BA; Versteeg KM; Fritz EA; Feldmann H; Hensley LE; Geisbert TW
    PLoS One; 2014; 9(4):e94355. PubMed ID: 24759889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
    Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for immunisation against Marburg and Ebola viruses.
    Geisbert TW; Bausch DG; Feldmann H
    Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 12. A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
    Woolsey C; Borisevich V; Agans KN; O'Toole R; Fenton KA; Harrison MB; Prasad AN; Deer DJ; Gerardi C; Morrison N; Cross RW; Eldridge JH; Matassov D; Geisbert TW
    J Infect Dis; 2023 Nov; 228(Suppl 7):S660-S670. PubMed ID: 37171813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus.
    Falzarano D; Feldmann F; Grolla A; Leung A; Ebihara H; Strong JE; Marzi A; Takada A; Jones S; Gren J; Geisbert J; Jones SM; Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1082-9. PubMed ID: 21987745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
    Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H
    J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ebola and Marburg viruses: the humans strike back].
    Alazard-Dany N; Ottmann Terrangle M; Volchkov V
    Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose attenuated Vesiculovax vaccines protect primates against Ebola Makona virus.
    Mire CE; Matassov D; Geisbert JB; Latham TE; Agans KN; Xu R; Ota-Setlik A; Egan MA; Fenton KA; Clarke DK; Eldridge JH; Geisbert TW
    Nature; 2015 Apr; 520(7549):688-691. PubMed ID: 25853476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
    Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
    Front Immunol; 2018; 9():3071. PubMed ID: 30723475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques.
    Marzi A; Fletcher P; Feldmann F; Saturday G; Hanley PW; Feldmann H
    Lancet Microbe; 2023 Mar; 4(3):e171-e178. PubMed ID: 36739878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
    Daddario-DiCaprio KM; Geisbert TW; Ströher U; Geisbert JB; Grolla A; Fritz EA; Fernando L; Kagan E; Jahrling PB; Hensley LE; Jones SM; Feldmann H
    Lancet; 2006 Apr; 367(9520):1399-404. PubMed ID: 16650649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates.
    Geisbert TW; Daddario-DiCaprio KM; Williams KJ; Geisbert JB; Leung A; Feldmann F; Hensley LE; Feldmann H; Jones SM
    J Virol; 2008 Jun; 82(11):5664-8. PubMed ID: 18385248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.